Sequent-Viyash merger effective; new MD/CEO and CFO appointed

Cfo ResignedCeo Appointed ExternalKmp ResignedManagement Changes View source PDF Explain this filing

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹211.29

prior close

₹210.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.9%+0.4% vs market

Pharmaceuticals peers, median of 156sector-0.8%+0.3% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.8

15m

+0.6

30m

+2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.9+0.4-0.8+0.3

Next day

-1.1-1.2+0.1-0.9-0.2

-0.4+0.0-0.5-0.0-0.4

+3.4+1.4+2.0+0.2+3.2

+2.8+1.5+1.3+0.5+2.3

+1.2+0.9+0.3+0.0+1.2

-1.4-0.4-1.0-0.8-0.6

15d

-5.3-0.3-5.1-0.3-5.1

-2.7-4.2+1.5-3.7+1.0

+4.1-1.7+5.8-3.7+7.9

-9.6-11.4+1.8-11.3+1.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Composite scheme of amalgamation with Viyash and others became effective December 16, 2025. Sequent allotted 18.19 crore equity shares to Viyash shareholders at 56 shares per 100 ratio and 2.03 crore warrants at Rs 181.94 each. Board appointed Dr. Haribabu Bodepudi (ex-Mylan COO/CEO) as MD and Group CEO for 2 years. Rajaram Narayanan redesignated as CEO for Animal Health. Srinivas Vasireddy joined as whole-time director. Ramakant Singani appointed CFO from Jan 1, 2026, replacing Saurav Bhala who resigned.

Likely market impact

Share capital rises sharply via 18.19 crore new shares plus convertible warrants, causing dilution. New leadership team takes charge from Jan 2026.